1983/10/01 by Marc A. Judson, Haroon Rashid Chaudhry, Haroon Chaudhry +5 · 1 citation
Biochemistry, Genetics and Molecular Biology · Decision Sciences · Materials Science · Medicine · #Amyloidosis: Diagnosis, Treatment, Outcomes #Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis #Nuclear Materials and Properties #Risk and Safety Analysis #Sarcoidosis and Beryllium Toxicity Research
paper · pdf · doi:10.1016/j.rmed.2015.01.019
openalex publication_date 1983/10/01 · openalex created_date 2016/06/24 · openalex updated_date 2026/06/24
Our cohort of sarcoidosis clinic patients who received ≤500 mg of prednisone in the previous year had an improved HRQoL compared to patients receiving >500 mg on the basis of two sarcoidosis-specific PROs after adjusting for severity of illness. These data support the need to measure HRQoL in sarcoidosis trials, and suggest that the search should continue for effective alternative medications to corticosteroids.